"Showcasing INIBO's Competitiveness in the Global Market"

Inibio announced on June 16 that it will participate as a Diamond Sponsor in the global medical aesthetics conference, "AMWC Korea 2026," which will be held at the Grand InterContinental Parnas in Gangnam-gu, Seoul, from June 19 to June 20.


During the conference, Inibio will operate an independent booth and host a sponsor symposium, where it will introduce its botulinum toxin brand "INIBO" to global medical professionals and industry stakeholders.

Inibio to Participate in AMWC Korea... INIBO Symposium to Be Held View original image

At the INIBO sponsor symposium, scheduled for June 20, a variety of clinical cases will be presented under the theme "Clinical Diversification of Botulinum Toxin INIBO (CCUG7968): Refinement and Expansion of Therapeutic Approaches."


Throughout the event, Inibio will also run a "Global Experts Program," inviting medical professionals and partners from key countries such as Brazil, China, and Peru. The program includes visits to Inibio's Bucheon production facility, live seminars at medical institutions, and introductions to products and manufacturing processes, allowing participants to directly observe the actual production site and clinical application cases.



An Inibio representative stated, "Participating in AMWC Korea this year will be a significant opportunity to highlight the clinical value and manufacturing competitiveness of INIBO in the global market." The representative added, "Building on our recent product approval in Peru, we will further accelerate our entry into global markets, including Brazil—the largest market in Latin America—and beyond."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing